Open AccessComparison of topical nepafenac 0.1% with intravitreal dexamethasone implant for the treatment of Irvine-Gass syndrome
Author(s) -
Hande Güçlü,
Vuslat Gürlü
Publication year - 2019
Publication title -
international journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.634
H-Index - 29
eISSN - 2227-4898
pISSN - 2222-3959
DOI - 10.18240/ijo.2019.02.12
Subject(s) - medicine , ophthalmology , phacoemulsification , macular edema , visual acuity , intraocular pressure , fundus (uterus) , dexamethasone , implant , diabetic retinopathy , intraocular lens , surgery , diabetes mellitus , endocrinology
To compare safety and efficacy of intravitreal dexamethasone (IVD) implant with topical nepafenac (TN) 0.1% in previously untreated Irvine-Gass syndrome (IGS) in clinical practice.